Research shows that DOPA protects against melanoma

People with light skin tones are far more likely to develop melanoma skin cancer than people with dark skin tones. This large disparity results from far more than can be explained by the UV protective effects of melanin pigment, and results in large part from the melanin precursor DOPA, and its ability to inhibit CHRM1, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

This post was originally published on this site

Skip The Dishes Referral Code - Consult a Lawyer Online in a variety of legal subjects